Fig. 2From: Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testingSchematic diagram of the serological tests used for evaluation of individuals with or without SARS-CoV-2 infectionBack to article page